Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRSD
7026
State Street Short Duration IG Public & Private Credit ETF
PRSD
$114M
| $1.16M | ﹤0.01% |
+46,222
| New | +$1.16M |
|
7027
PUT
Leggett & Platt
LEG
$1.28B
| $1.16M | ﹤0.01% |
105,300
+41,000
| +64% | +$403K |
|
|
NEBX
7028
Tradr 2X Long NBIS Daily ETF
NEBX
$258M
| $1.16M | ﹤0.01% |
123,171
+107,019
| +663% | +$1.81M |
|
7029
CALL
SouthState Bank Corp
SSB
$10.7B
| $1.16M | ﹤0.01% |
12,300
+1,500
| +14% | +$139K |
|
|
KMTS
7030
Kestra Medical Technologies
KMTS
$1.64B
| $1.16M | ﹤0.01% |
+43,643
| New | +$1.12M |
|
7031
Paysign
PAYS
$763M
| $1.16M | ﹤0.01% |
224,739
+77,378
| +53% | +$417K |
|
7032
PUT
Veritone
VERI
$100M
| $1.16M | ﹤0.01% |
248,800
+210,500
| +550% | +$1.13M |
|
7033
Enlight Renewable Energy
ENLT
$11.7B
| $1.16M | ﹤0.01% |
25,449
-263,408
| -91% | -$9.84M |
|
7034
PUT
Janux Therapeutics
JANX
$1.04B
| $1.16M | ﹤0.01% |
83,800
+69,300
| +478% | +$1.63M |
|
|
ARES.PRB
7035
Ares Management Corp 6.75% Series B Preferred Stock
ARES.PRB
$1.34B
| $1.16M | ﹤0.01% |
+22,919
| New | +$1.13M |
|
7036
CALL
EyePoint Inc
EYPT
$472M
| $1.15M | ﹤0.01% |
63,200
-25,000
| -28% | -$354K |
|
|
ONT
7037
CALL
Onterris Inc
ONT
$565M
| $1.15M | ﹤0.01% |
46,500
-6,300
| -12% | -$166K |
|
|
EUAD
7038
CALL
Select STOXX Europe Aerospace & Defense ETF
EUAD
$1.24B
| $1.15M | ﹤0.01% |
27,400
-6,800
| -20% | -$293K |
|
7039
PUT
American Battery Technology Co
ABAT
$321M
| $1.15M | ﹤0.01% |
345,500
+263,700
| +322% | +$1.23M |
|
7040
Franklin US Mid Cap Multifactor Index ETF
FLQM
$1.56B
| $1.15M | ﹤0.01% |
20,504
-6,356
| -24% | -$357K |
|
7041
Intercorp Financial Services
IFS
$5.97B
| $1.15M | ﹤0.01% |
27,232
+19,923
| +273% | +$819K |
|
7042
CALL
RenaissanceRe
RNR
$13.3B
| $1.15M | ﹤0.01% |
4,100
-18,400
| -82% | -$4.84M |
|
7043
PUT
Red Rock Resorts
RRR
$3.64B
| $1.15M | ﹤0.01% |
18,600
-23,800
| -56% | -$1.39M |
|
7044
Vanguard Total World Stock ETF
VT
$80.7B
| $1.15M | ﹤0.01% |
8,167
+6,037
| +283% | +$844K |
|
7045
CALL
Centuri Holdings
CTRI
$2.29B
| $1.15M | ﹤0.01% |
45,600
+33,400
| +274% | +$747K |
|
7046
CALL
Phathom Pharmaceuticals
PHAT
$748M
| $1.15M | ﹤0.01% |
69,300
+30,900
| +80% | +$441K |
|
7047
Exagen
XGN
$160M
| $1.15M | ﹤0.01% |
188,458
+72,228
| +62% | +$657K |
|
7048
PUT
iShares S&P 500 Value ETF
IVE
$50.1B
| $1.15M | ﹤0.01% |
+5,400
| New | +$1.13M |
|
7049
CALL
Capital Southwest
CSWC
$1.57B
| $1.15M | ﹤0.01% |
+51,700
| New | +$1.09M |
|
7050
PUT
Grupo Cibest SA
CIB
$23.1B
| $1.14M | ﹤0.01% |
18,000
+300
| +2% | +$18K |
|
Similar funds
Ken Griffin's Q4 2025 Portfolio in Review
As of Q4 2025, Ken Griffin held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Griffin's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,362 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Ken Griffin's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Ken Griffin added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Ken Griffin's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Ken Griffin fully exited WEX in Q4 2025, selling an estimated $131M.
- Ken Griffin's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Ken Griffin opened 2,078 new positions and closed 2,191 in Q4 2025.
- Ken Griffin's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.